With 20 years’ experience in the pharmaceutical industry, including time in roles in Quality Assurance, Clinical Operations, process management, and information/records management, Austin brings a passion to driving for the absence of errors that matter and is committed to enhancing patient-centric work processes. He currently leads the Research and Clinical Development Quality Operations (Hematology/Nephrology) team at Alexion and is responsible for the implementation of Risk Based Quality Management across the Alexion portfolio.

Shaheen Limbada is the Executive Vice President of Global Clinical Operations at Veristat. In this role, Mr. Limbada oversees Global Clinical Operations including, clinical monitoring, project management, site management and medical affairs. Mr. Limbada graduated from the University of Toronto and quickly began his career in clinical trials with AstraZeneca Canada Inc. With over 20 years of experience running clinical trials in both the sponsor and CRO setting, including building and successfully selling his own CRO, he excels in the areas of risk management, project management, patient recruitment and clinical study conduct and governance. He joined Veristat through the recent acquisition of Topstone Research, a Canadian-based CRO that he co-founded and held the position of Managing Director. Prior to Topstone, he worked in clinical operations, project management and leadership roles at various clinical research organizations (CROs) and pharmaceutical firms.

Ms. Chelsey Ryan, Senior Manager, Clinical Trials Management, has more than 10 years of diverse experience in clinical research operations management, project management and technical systems management experience.